Prognostic significance of DNA image cytometry in Libyan breast cancer

Oncology (Switzerland)

Volumn 83, Issue 3, 2012, Pages 165-176

  Ermiah, Eramah ^a,c   Abdalla, Fathi ^b,d   Buhmeida, Abdelbaset ^e   Alshrad, Moftah ^a   Salem, Nada ^f   Pyrhnen, Seppo ^a   Collan, Yrj ^b  

^a African Oncology Institute   (Libyan Arab Jamahiriya)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c Department of Oncology ^*  (Finland)

^d Misurata Cancer Institute   (Libyan Arab Jamahiriya)

^e Center of Excellence in Genomic Medicine Research   (Saudi Arabia)

^f KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

DNA content; Libyan breast cancer; Prognosis; Static image DNA cytometry

Indexed keywords

ANTHRACYCLINE; CELL NUCLEUS DNA; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; ADVANCED CANCER; AGE; AGED; ANEUPLOIDY; ARTICLE; BREAST CANCER; CANCER SURVIVAL; COMPUTER SYSTEM; CORRELATION ANALYSIS; DIPLOIDY; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; DNA CONTENT; EVALUATION; FEMALE; FEULGEN STAINING; FOLLOW UP; HISTOGRAM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE CYTOMETRY; LIBYAN ARAB JAMAHIRIYA; LYMPH NODE; MAJOR CLINICAL STUDY; MASTECTOMY; OVERALL SURVIVAL; PARAMETERS; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; S PHASE FRACTION; SURVIVAL TIME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; IMAGE CYTOMETRY; IMAGE PROCESSING, COMPUTER-ASSISTED; LIBYA; MIDDLE AGED; PLOIDIES; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84865054960     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000339788     Document Type: Article

References (44)

1. Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale G: Breast cancer. Lancet 2005;365:1727-1741. (Pubitemid 40719108)
2. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108. (Pubitemid 40372904)
3. Abulkhair O, Saghir N, Sedky L, Saadedin A, Elzahwary H, Siddiqui N, Al Saleh M, Geara F, Birido N, Al-Eissa N, et al: Modification and implementation of NCCN guidelines on breast cancer in the Middle East and North Africa region. J Natl Compr Canc Netw 2010;8(suppl 3):S8-S15.
4. Stapleton JM, Mullan PB, Dey S, Hablas A, Gaafar R, Seifeldin IA, Banerjee M, Soliman AS: Patient-mediated factors predicting earlyand late-stage presentation of breast cancer in Egypt. Psychooncology 2011;20:532-537.
5. Collan YU, Eskelinen MJ, Nordling SA, Lipponen P, Pesonen E, Kumpusalo LM, Pajarinen P, Kettunen KO: Prognostic studies in breast cancer: multivariate combination of nodal status, proliferation index, tumor size, and DNA ploidy. Acta Oncol 1994;33:873-878.
6. Friedrich K, Scheithauer J, Dimmer V, Meyer W, Theissig F, Haroske G, Kunze KD: DNA ploidy and chromosomal imbalances in invasive ductal breast cancer: a comparative study of DNA image cytometry and comparative genomic hybridization (CGH). Anal Cell Pathol 2000;20:69-82.
7. Yildirim-Assaf S, Coumbos A, Hopfenmuller W, Foss HD, Stein H, Kuhn W: The prognostic significance of determining DNA content in breast cancer by DNA image cytometry: the role of high grade aneuploidy in node negative breast cancer. J Clin Pathol 2007;60:649-655. (Pubitemid 46975219)
8. Abussa A: Hospital cancer registry annual report 2006. Sabratha, African Oncology Institute, 2007, pp 18-20.
9. El Mistiri M, Verdecchia A, Rashid I, El Sahli N, El Mangush M, Federico M: Cancer incidence in eastern Libya: the first report from the Benghazi Cancer Registry, 2003. Int J Cancer 2007;120:392-397. (Pubitemid 44956852)
10. Boder J, Abdalla F, Elfageih M, Abusaa A, Alfagieh M, Buhmeida A, Collan Y: Breast cancer patients in Libya: comparison with European and central African patients. Oncology Letters 2011;2:323-330.
11. Najjar H, Easson A: Age at diagnosis of breast cancer in Arab nations. Int J Surg 2010;8:448-452.
12. Bocking A, Giroud F, Reith A: Consensus report of the European Society for Analytical Cellular Pathology task force on standardization of diagnostic DNA image cytometry. Anal Quant Cytol Histol 1995;17:1-7.
13. Auer GU, Caspersson TO, Wallgren AS: DNA content and survival in mammary carcinoma. Anal Quant Cytol 1980;2:161-165. (Pubitemid 10018801)
14. Erhardt K, Auer G: Mammary carcinoma: DNA analysis in areas showing different histological features in the same tumor. Acta Pathol Microbiol Scand A 1986;94:21-28. (Pubitemid 16013757)
15. Bocking A, Chatelain R, Biesterfeld S, Noll E, Biesterfeld D, Wohltmann D, Goecke C: DNA grading of malignancy in breast cancer: prognostic validity, reproducibility and comparison with other classifications. Anal Quant Cytol Histol 1989;11:73-80. (Pubitemid 19195623)
16. Tsutsui S, Ohno S, Murakami S, Hachitanda Y, Oda S: Prognostic value of DNA ploidy in 653 Japanese women with node-negative breast cancer. Int J Clin Oncol 2001;6:177-182. (Pubitemid 32899618)
17. Wenger CR, Beardslee S, Owens MA, Pounds G, Oldaker T, Vendely P, Pandian MR, Harrington D, Clark GM, McGuire WL: DNA ploidy, S-phase, and steroid receptors in more than 127, 000 breast cancer patients. Breast Cancer Res Treat 1993;28:9-20. (Pubitemid 24018192)
18. Spiethoff A, Schenck A, Bohrer M: Relationship of DNA ploidy to hormone receptor status and proliferation in invasive breast carcinoma. J Cancer Res Clin Oncol 2000;126:707-710.
19. Yuan J, Hennessy C, Corbett IP, Dykin R, Givan AL, Shenton BK, Henry JA, Wright C, Lennard TW: Node negative breast cancer: the prognostic value of DNA ploidy for longterm survival. Br J Surg 1991;78:844-848.
20. Baldetorp B, Ferno M, Fallenius A, Fallenius-Vecchi G, Idvall I, Olsson H, Sigurdsson H, Akerman M, Killander D: Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry. Cytometry 1992;13:577-585.
21. Zhang S, Yuan Y, Wang X: Prognosis prediction of S-phase fraction and p53, c-erbB-2, estrogen receptor, progesterone receptor in axillary node-negative breast cancer (in Chinese). Zhonghua Wai Ke Za Zhi 1997;35:475-477.
22. Jones S, Clark G, Koleszar S, Ethington G, Mennel R, Paulson S, Brooks B, Kerr R, Denham C, Savin M, et al: Low proliferative rate of invasive node-negative breast cancer predicts for a favorable outcome: a prospective evaluation of 669 patients. Clin Breast Cancer 2001;1:310-317.
23. McBride R, Hershman D, Tsai WY, Jacobson JS, Grann V, Neugut AI: Within-stage racial differences in tumor size and number of positive lymph nodes in women with breast cancer. Cancer 2007;110:1201-1208. (Pubitemid 47435589)
24. Abdalla F, Boder J, Markus R, Hashmi H, Buhmeida A, Collan Y: Correlation of nuclear morphometry of breast cancer in histological sections with clinicopathological features and prognosis. Anticancer Res 2009;29:1771-1776.
25. American Joint Committee on Cancer: AJCC Cancer Staging Manual, ed 5. Philadelphia, Lippincott-Raven, 1997.
26. Allred DC, Harvey JM, Berardo M, Clark GM: Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998;11:155-168. (Pubitemid 28144151)
27. Hedley DW, Friedlander ML, Taylor IW: Application of DNA flow cytometry to paraffinembedded archival material for the study of aneuploidy and its clinical significance. Cytometry 1985;6:327-333. (Pubitemid 15060317)
28. Gaub J, Auer G, Zetterberg A: Quantitative cytochemical aspects of a combined feulgennaphthol yellow S staining procedure for the simultaneous determination of nuclear and cytoplasmic proteins and DNA in mammalian cells. Exp Cell Res 1975;92:323-332.
29. Bohnhoff GL: Setting up proper illumination on your microscope. Am J Med Technol 1979;45:650-651.
30. Haroske G, Giroud F, Reith A, Bocking A: 1997 ESACP consensus report on diagnostic DNA image cytometry. Part I: basic considerations and recommendations for preparation, measurement and interpretation. European Society for Analytical Cellular Pathology. Anal Cell Pathol 1998;17:189-200.
31. Masuda H, Masuda N, Kodama Y, Ogawa M, Karita M, Yamamura J, Tsukuda K, Doihara H, Miyoshi S, Mano M, et al: Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients. Cancer Chemother Pharmacol 2011;67:911-917.
32. Geiger T, Madden SF, Gallagher WM, Cox J, Mann M: Proteomic portrait of human breast cancer progression identifies novel prognostic markers. Cancer Res 2012;72:2428-2439.
33. Karra H, Pitkanen R, Nykanen M, Talvinen K, Kuopio T, Soderstrom M, Kronqvist P: Securin predicts aneuploidy and survival in breast cancer. Histopathology 2012;60:586-596.
34. Bazan V, Migliavacca M, Zanna I, Tubiolo C, Corsale S, Calo V, Amato A, Cammareri P, Latteri F, Grassi N, et al: DNA ploidy and Sphase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients: result of a 5-year prospective study. J Cancer Res Clin Oncol 2002;128:650-658. (Pubitemid 35435840)
35. Cohen C: Image cytometric analysis in pathology. Hum Pathol 1996;27:482-493. (Pubitemid 26149464)
36. Rajagopalan H, Lengauer C: Aneuploidy and cancer. Nature 2004;432:338-341. (Pubitemid 39551662)
37. Jaffrey RG, Pritchard SC, Clark C, Murray GI, Cassidy J, Kerr KM, Nicolson MC, McLeod HL: Genomic instability at the BUB1 locus in colorectal cancer, but not in non-small cell lung cancer. Cancer Res 2000;60:4349-4352. (Pubitemid 32103609)
38. Wong SW, Rangan AM, Bilous AM, Boyages J, Gebski V, Benson EM: The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting. Pathology 1999;31:90-94. (Pubitemid 29264051)
39. Peiro G, Lerma E, Climent MA, Segui MA, Alonso MC, Prat J: Prognostic value of Sphase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis. Mod Pathol 1997;10:216-222. (Pubitemid 27130459)
40. Fisher B, Jeong JH, Bryant J, Anderson S, Dignam J, Fisher ER, Wolmark N: Treatment of lymph-node-negative, oestrogen-receptorpositive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials. Lancet 2004;364:858-868. (Pubitemid 39221063)
41. Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN: Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 2007;608:1-22.
42. Kang HS, Youn YK, Oh SK, Choe KJ, Noh DY: Flow cytometric analysis of primary tumors and their corresponding metastatic nodes in breast cancer. Breast Cancer Res Treat 2000;63:81-87.
43. Moureau-Zabotto L, Bouchet C, Cesari D, Uzan S, Lefranc JP, Antoine M, Genestie C, Deniaud-Alexandre E, Bernaudin JF, Touboul E, et al: Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer. Breast Cancer Res Treat 2005;91:61-71. (Pubitemid 40684939)
44. Chassevent A, Jourdan ML, Romain S, Descotes F, Colonna M, Martin PM, Bolla M, Spyratos F: S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study. Clin Cancer Res 2001;7:909-917. (Pubitemid 32708729)